About Tibet Aim Pharm. Inc. Company

The company was founded in December 2003 and is a comprehensive pharmaceutical enterprise integrating R&D, production and sales. The marketing network is spread all over the country. The company has long been committed to the treatment of chronic geriatric conditions such as diabetes, cardiovascular disease, and the development and research of core products in the field of gynecology and obstetrics. The company's core products are Yiming Tianping Miglitol tablets, Xintongguo peel injection, Yiming Xinnuosucarb oxytocin injection, Yimingmei Red Gold Medication tablets, and Vicofen Aceclofenac enteric tablets, etc. have all entered the national medical insurance catalogue. General medicine products cover a wide range of antibiotics, anti-allergies, and digestive systems. The company's main business is independent pharmaceutical production business, third-party cooperative drug sales business, API business, pharmaceutical raw material sales business, and drug promotion service business. The main products are miglitol tablets, aceclofenac enteric tablets, red gold dissolving tablets, montmorillonite powder, domperidone tablets, azithromycin capsules, loratadine tablets, melon peel injections, nalmefene hydrochloride injections, cabecitracin injections, digoxin injections, dimefline hydrochloride injections, multivitamins for injection (12), sodium acetate rhodiola injection, rhododendron phosphate injections, various trace element injections, etc. Corporate honors: The company has successively won honors such as “Tibet Autonomous Region Science and Technology Small and Medium Enterprise”, “National High-tech Enterprise”, “National Science and Technology Incubation Enterprise”, “Tibet National Science and Technology Incubation Enterprise”, “China Cardiovascular and Cerebrovascular Disease Diagnosis and Treatment Industry Technology Innovation Strategic Alliance (Tibet)”, and “China Patent Excellence Award”.